OCX - OncoCyte Corp - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

OCX is currently covered by 4 analysts with an average price target of $16.11. This is a potential upside of $13.46 (507.92%) from yesterday's end of day stock price of $2.65.

OncoCyte Corp's activity chart (see below) currently has 27 price targets and 43 ratings on display. The stock rating distribution of OCX is 87.5% BUY and 12.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.87% with an average time for these price targets to be met of 58.45 days.

Highest price target for OCX is $8, Lowest price target is $4.25, average price target is $5.06.

Most recent stock forecast was given by THOMAS FLATEN from LAKE STREET on 21-May-2025. First documented stock forecast 24-Mar-2016.

Currently out of the existing stock ratings of OCX, 14 are a BUY (87.5%), 2 are a HOLD (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$8

$5.35 (201.89%)

$5

24 days ago
(21-May-2025)

1/6 (16.67%)

$4.93 (160.59%)

204

Buy

$4.25

$1.6 (60.38%)

$4.25

1 months 1 days ago
(13-May-2025)

2/11 (18.18%)

$1.48 (53.43%)

58

Buy

$5

$2.35 (88.68%)

$5

1 years 1 months 30 days ago
(15-Apr-2024)

0/4 (0%)

$2.47 (97.63%)

Hold

$3

$0.35 (13.21%)

$3.5

1 years 7 months 1 days ago
(13-Nov-2023)

2/5 (40%)

$0.24 (8.70%)

2

Buy

$25

$22.44 (876.56%)

$62

3 years 21 days ago
(24-May-2022)

1/2 (50%)

$5.31 (26.97%)

16

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is OCX (OncoCyte Corp) average time for price targets to be met?

On average it took 58.45 days on average for the stock forecasts to be realized with a an average price target met ratio 37.87

Which analyst has the current highest performing score on OCX (OncoCyte Corp) with a proven track record?

PAUL KNIGHT

Which analyst has the most public recommendations on OCX (OncoCyte Corp)?

Paul Knight works at KEYBANK and has 6 price targets and 4 ratings on OCX

Which analyst is the currently most bullish on OCX (OncoCyte Corp)?

Steven Mah with highest potential upside - $137.35

Which analyst is the currently most reserved on OCX (OncoCyte Corp)?

Keay Nakae with lowest potential downside - -$1.12

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?